% | $
Quotes you view appear here for quick access.

Synta Pharmaceuticals Corp. Message Board

  • rannussbaum rannussbaum Jul 28, 2012 2:31 PM Flag

    SNTA R&D for big pharma

    SNTA is a good example how to make money from the current situation. big pharma co's will stop spending 1B to dev drug from pre clinical till launch, they will buy them at 800M.
    SNAT will be bought by GSK, MRK, PFE or SNY.
    its a 600M drug in sales, so its 1.5B M&A within one year
    if the KRAS or the ALK for lung is working - we will see a nice run.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
0.2682-0.0118(-4.21%)Jun 29 4:00 PMEDT